Inventor · disambiguated record
Patrick Y. Lu
Also filed as: LU PATRICK · LU PATRICK Y
21 granted patents·37 pending applications·171 citations·filing 2000–2024
95Inventor score
Top patents by PatentIndex Score
58 records- 0193US11058779B2Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infectionSIRNAOMICS INC·Filed 2016·Granted Jul 13, 2021·18 cites·20 claims
- 0292US7534878B2Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseasesINTRADIGM CORP·Filed 2007·Granted May 19, 2009·22 cites·32 claims
- 0389US7893244B2Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseasesINTRADIGM CORP·Filed 2008·Granted Feb 22, 2011·7 cites·29 claims
- 0489US7723316B2Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseasesINTRADIGM CORP·Filed 2007·Granted May 25, 2010·12 cites·47 claims
- 0588US7786092B2Composition and method of RNAi therapeutics for treatment of cancer and other neovascularization diseasesINTRADIGM CORP·Filed 2009·Granted Aug 31, 2010·11 cites·27 claims
- 0687US12006500B2Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV)SIRNAOMICS INC·Filed 2021·Granted Jun 11, 2024·2 cites·16 claims
- 0787US9642873B2Combinations of TGFβ and COX-2 inhibitors and methods for their therapeutic applicationLU PATRICK Y·Filed 2011·Granted May 9, 2017·7 cites·37 claims
- 0887US8541568B2Compositions and methods using siRNA molecules for treatment of gliomasYAN HAI·Filed 2009·Granted Sep 24, 2013·11 cites·16 claims
- 0986US12029786B2Composition and method of mRNA vaccines against novel coronavirus infectionRNAIMMUNE INC·Filed 2021·Granted Jul 9, 2024·3 cites·19 claims
- 1085US12054714B2Peptide docking vehicle for targeted nucleic acid deliverySIRNAOMICS INC·Filed 2020·Granted Aug 6, 2024·1 cites·13 claims
- 1185US9012622B2Compositions and methods using siRNA molecules and siRNA cocktails for the treatment of breast cancerLU PATRICK Y·Filed 2009·Granted Apr 21, 2015·7 cites·12 claims
- 1284US10195368B2Handheld high frequency ultrasonic nebulizer for whole respiratory tract drug deliveryCHANGZHOU ZHENGYUAN MEDICAL TECH CO LTD·Filed 2014·Granted Feb 5, 2019·46 cites·12 claims
- 1384USRE46873EMulti-targeted RNAi therapeutics for scarless wound healing of skinSIRNAOMICS INC·Filed 2008·Granted May 29, 2018·5 cites·21 claims
- 1484US7893243B2Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseasesINTRADIGM CORP·Filed 2007·Granted Feb 22, 2011·6 cites·35 claims
- 1583US8735567B2Multi-targeted RNAi therapeutics for scarless wound healing of skinLU PATRICK Y·Filed 2008·Granted May 27, 2014·5 cites·12 claims
- 1681US11697813B2Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosisSIRNAOMICS INC·Filed 2017·Granted Jul 11, 2023·2 cites·11 claims
- 1776US8691781B2Compositions for treating respiratory viral infections and their useTANG QINGQUAN·Filed 2005·Granted Apr 8, 2014·4 cites·21 claims
- 1870US7781414B2Targets for tumor growth inhibitionINTRADIGM CORP·Filed 2004·Granted Aug 24, 2010·2 cites·31 claims
- 1967US12280105B2Compositions and methods of mRNA vaccines against novel coronavirus infectionRNAIMMUNE INC·Filed 2024·Granted Apr 22, 2025·0 cites·30 claims
- 2067US2024175032A1Compositions and methods for inhibiting expression of pcsk9SIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 2167US2024139228A1Pharmaceutical composition and applications thereofLU ALAN Y·Filed 2023·Application pending·0 cites
- 2267US2023392154A1Targeted nucleic acid therapy for hepatitis bSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 2365US2023355656A1Compositions and methods for treatment of skin cancersSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 2463US2023250432A1siRNA-Copolymer Compositions And Methods Of Use For Treatment Of Liver CancerSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 2562US2023323358A1COMPOSITION AND USE OF siRNAs AGAINST VEGFR2 AND TGF-BETA1 IN COMBINATION THERAPY FOR CANCERSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 2662US2022282258A1CO-DELIVERY OF TGF-B siRNA AND PDL1 siRNA TO TREAT CANCERSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 2761US2022145301A1siRNA/Nanoparticle Formulations for Treatment of Middle-East Respiratory Syndrome Coronaviral InfectionSIRNAOMICS INC·Filed 2021·Application pending·0 cites
- 2861US2008153771A1Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseasesLIU YIJIA·Filed 2007·Application pending·0 cites
- 2960US2022331441A1Tumor-Targeting Polypeptide Nanoparticle Delivery System for Nucleic Acid TherapeuticsSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3059US2021324384A1SILENCING TGF-BETA 1 and COX2 USING siRNAs DELIVERED in a POLYPEPTIDE NANOPARTICLE ALONE and in COMBINATION with IMMUNE CHECKPOINT INHIBITORS to TREAT CANCERSIRNAOMICS INC·Filed 2021·Application pending·0 cites
- 3159US2010203036A1Targets for tumor growth inhibitionINTRADIGM CORP·Filed 2009·Application pending·0 cites
- 3259US2022387599A1Oligonucleotides with nucleoside analogsSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3358US2025011788A1Nucleic acid interference pharmaceutical composition, and drug for treating colorectal cancer, gastric cancer, and prostate cancerSIRNAOMICS BIOPHARMACEUTICALS SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 3457US2024156966A1A sirna drug, a pharmaceutical composition, a sirna-small molecule drug conjugate, and the application thereofSIRNAOMICS BIOPHARMACEUTICALS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 3556US2025263704A1Nucleic acid-polypeptide nano-pharmaceutical compostion for treating and preventing human papilloma virus infectionSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3655US2022333108A1Combinations of sirnas with sirnas against sulf2 or gpc3 for use in treating cancerSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3753US2021162067A1Composition and Methods of Controllable Co-Coupling Polypeptide Nanoparticle Delivery System for Nucleic Acid TherapeuticsSIRNAOMICS INC·Filed 2020·Application pending·0 cites
- 3853US2023300989A1Circuit board etching device and method for improving etching factorTEMG TAI PCB MACHINERY CO LTD·Filed 2022·Application pending·0 cites
- 3952US2022054645A1Targeted Delivery of Therapeutic MoleculesSIRNAOMICS INC·Filed 2021·Application pending·0 cites
- 4052US2011124710A1Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseasesINTRADIGM CORP·Filed 2011·Application pending·0 cites
- 4150US2018369273A1Pharmaceutical Composition and Applications ThereofSIRNAOMICS INC·Filed 2016·Application pending·0 cites
- 4248US2007237718A1Multi-disciplinary approach to validating or indentifying targets using an in vivo systemLU PATRICK Y·Filed 2007·Application pending·0 cites
- 4348US2009069257A1Method of achieving persistent Transgene expressionENNIST DAVID·Filed 2007·Application pending·0 cites
- 4447US9868952B2Compositions and methods for “resistance-proof” SiRNA therapeutics for influenzaSIRNAOMICS INC·Filed 2013·Granted Jan 16, 2018·0 cites·22 claims
- 4547US2007219118A1Therapeutic methods for nucleic acid delivery vehiclesINTRADIGM CORP·Filed 2006·Application pending·0 cites
- 4646US2012115923A1Sirna Compositions Promoting Scar-Free Wound Healing of Skin and Methods for Wound TreatmentHE WEI-WU·Filed 2006·Application pending·0 cites
- 4746US2020108089A1Gemcitabine Derivatives for Cancer TherapySUZHOU SIRNAOMICS BIOPHARMACEUTICALS CO LTD·Filed 2018·Application pending·0 cites
- 4846US2011038849A1Inhibitory polynucleotide compositions and methods for treating cancerINTRADIGM CORP·Filed 2006·Application pending·0 cites
- 4944US2013123330A1Dual Targeted siRNA Therapeutics for Treatment of Diabetic Retinopathy and Other Ocular Neovascularization DiseasesLU PATRICK Y·Filed 2012·Application pending·0 cites
- 5043US2013115295A1Rare Earth-Doped Up-Conversion Nanoparticles for Therapeutic and Diagnostic ApplicationsWANG QIANG·Filed 2010·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Patrick Y. Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →